课题基金 / 基金详情

Integrating Patient Preferences into Quantitative Benefit-Risk Assessment of the Sodium-Glucose Transport Protein 2 Inhibitors

Integrating Patient Preferences into Quantitative Benefit-Risk Assessment of the Sodium-Glucose Transport Protein 2 Inhibitors
将患者偏好纳入钠-葡萄糖转运蛋白 2 抑制剂的定量效益-风险评估中
批准号：
363844
负责人：
Donnan Jennifer R
金额：
$12.02万
依托单位：
Memorial University of Newfoundland
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-11-01 至 2019-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=363844&lang=en
关键词：
Choice Modelling Discrete Choice Experiment Drug Safety Network Meta-Analysis Patient Preferences Pharmacoepidemiology Policy Decision Making Quantitative Risk Benefit Analysis Sodium-Glucose Transporter 2 Inhibitor Type 2 Diabetes

项目摘要

项目成果

Donnan Jennifer R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Optimal treatment decisions surrounding drug therapies rely on information about the trade-offs among benefits and harms. Moreover, the selection of an appropriate drug therapy is very patient specific and should take into consideration not only the poten
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金